Aflatoxin Levels in Chronic Hepatitis B Patients with Cirrhosis or Hepatocellular Carcinoma in Balkesir, Turkey

dc.contributor.authorAydin, M.
dc.contributor.authorAydin, S.
dc.contributor.authorBacanli, M.
dc.contributor.authorBasaran, N.
dc.contributor.orcID0000-0003-4044-9366en_US
dc.contributor.orcID0000-0001-8581-8933en_US
dc.contributor.orcID0000-0002-6368-2745en_US
dc.contributor.pubmedID25894298en_US
dc.contributor.researcherIDHLX-0937-2023en_US
dc.contributor.researcherIDJ-1104-2013en_US
dc.contributor.researcherIDJ-1114-2013en_US
dc.date.accessioned2023-12-15T13:32:36Z
dc.date.available2023-12-15T13:32:36Z
dc.date.issued2015
dc.description.abstractAflatoxins, the secondary metabolites produced by species of naturally occurring Aspergilli, are commonly found in food such as cereals, dried fruits and juice, wine, beer and spices. They are hepatotoxic and are well known human carcinogens based on evidence from human studies. Aflatoxins are an environmental risk factor for the development of hepatocellular carcinoma (HCC). Chronic hepatitis B-infected patients are at increased risk of cirrhosis, hepatic failure and liver cancer. This study was designed to determine the serum aflatoxin B-1 (AFB(1)), aflatoxin B-2 (AFB(2)), aflatoxin G(1) (AFG(1)) and aflatoxin G(2) (AFG(2)) concentrations using high-pressure liquid chromatography (HPLC) in hepatitis B-infected patients with or without cirrhosis and liver cancer, alongside healthy controls in Balkesir, Turkey. The mean AFB(1) and total AF levels in patients without liver cancer and cirrhosis were significantly higher than healthy controls. The mean AFB(1) and total AF levels in patients with chronic hepatitis B and HCC were significantly higher than infected patients with or without cirrhosis. These results suggest that patients with chronic hepatitis B who are exposed to AFs are at increased risk for developing HCC, which might be prevented by reducing consumption of contaminated foods.en_US
dc.identifier.eissn1365-2893en_US
dc.identifier.endpage935en_US
dc.identifier.issn1352-0504en_US
dc.identifier.issue11en_US
dc.identifier.scopus2-s2.0-84943818336en_US
dc.identifier.startpage926en_US
dc.identifier.urihttp://hdl.handle.net/11727/11117
dc.identifier.volume22en_US
dc.identifier.wos000362450600008en_US
dc.language.isoengen_US
dc.relation.isversionof10.1111/jvh.12410en_US
dc.relation.journalJOURNAL OF VIRAL HEPATITISen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectaflatoxinsen_US
dc.subjectchronic hepatitis Ben_US
dc.subjectcirrhosisen_US
dc.subjecthepatocellular carcinomaen_US
dc.subjectTurkeyen_US
dc.titleAflatoxin Levels in Chronic Hepatitis B Patients with Cirrhosis or Hepatocellular Carcinoma in Balkesir, Turkeyen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: